COmbiNing Cutting and Drug-Eluting Balloon for Resistant Arteriovenous Fistula sTenOsis (CONCERTO)
CONCERTO
1 other identifier
interventional
19
1 country
1
Brief Summary
To evaluate the preliminary efficacy of combination of cutting and drug-coated balloon for the treatment of resistant AVF stenosis.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for phase_1
Started Aug 2018
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 15, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 30, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
June 30, 2019
CompletedFirst Submitted
Initial submission to the registry
July 17, 2023
CompletedFirst Posted
Study publicly available on registry
July 27, 2023
CompletedJuly 27, 2023
July 1, 2023
11 months
July 17, 2023
July 17, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Target lesion primary patency
Time from index treatment to repeat treatment of target lesion or thrombosis of circuit.
6 months after index procedure
Study Arms (1)
Treatment arm
EXPERIMENTALCutting and drug-coated balloon angioplasty
Interventions
Eligibility Criteria
You may qualify if:
- Failing mature upper limb AVF
- Resistant stenosis (\>30% residual stenosis) after optimal conventional balloon angioplasty (appropriately sized balloon, inflated up to rated burst pressure, at least twice for at least a minute per inflation)
- Patient is \>= 21 years of age
- Ability to provide informed consent
You may not qualify if:
- Thrombosed AVF
- Target lesion has a sharp angle (\> 45 degrees)
- Lesions requiring cutting balloon size \> 7 mm
- Coagulopathy or thrombocytopaenia that cannot be adequately managed for the procedure
- Contraindication to dual antiplatelet therapy
- Severe allergy to contrast media that cannot be adequately managed for the procedure
- Breast-feeding and/or pregnant females
- Male patients who are planning to father children during the trial period
- Unable to comply with follow up protocol (for instance, limited life expectancy)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Singapore General Hospital
Singapore, 168609, Singapore
Related Publications (1)
Wu CC, Lin MC, Pu SY, Tsai KC, Wen SC. Comparison of cutting balloon versus high-pressure balloon angioplasty for resistant venous stenoses of native hemodialysis fistulas. J Vasc Interv Radiol. 2008 Jun;19(6):877-83. doi: 10.1016/j.jvir.2008.02.016. Epub 2008 May 2.
PMID: 18503902BACKGROUND
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Kun Da Zhuang, MBBS
Singapore General Hospital
Study Design
- Study Type
- interventional
- Phase
- phase 1
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 17, 2023
First Posted
July 27, 2023
Study Start
August 15, 2018
Primary Completion
June 30, 2019
Study Completion
June 30, 2019
Last Updated
July 27, 2023
Record last verified: 2023-07